➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Colorcon
Mallinckrodt
Express Scripts
McKinsey

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Golimumab - Biologic Drug Details


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for golimumab

Identify potential brand extensions & biosimilar entrants

SponsorPhase
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
University of South FloridaPhase 2
University of California, San DiegoPhase 2

See all golimumab clinical trials

Recent Litigation for golimumab

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
ABBVIE INC. v. SANDOZ INC.2018-08-10
Celgene Corporation v. Aurobindo Pharma Limited2018-07-06
AMGEN INC. v. EMCURE PHARMACEUTICALS LTD.2018-06-28

See all golimumab litigation

PTAB Litigation
PetitionerDate
2017-12-20

See all golimumab litigation

Pharmacology for golimumab

Patent Text Search: US Patents for golimumab

These patents were identified by searching patent claims

Supplementary Protection Certificates for golimumab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
17C/054 Belgium   Get Started Free PRODUCT NAME: KEVZARA - SARILUMAB; AUTHORISATION NUMBER AND DATE: EU/1/17/1196 20170627
2020000000022 Italy   Get Started Free PRODUCT NAME: UPADACITINIB IN QUALSIASI FORMA PROTETTA DAL BREVETTO DI BASE(RINVOQ); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/19/1404, 20191218
2041177/01 Switzerland   Get Started Free PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66424 20.04.2018
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Johnson and Johnson
AstraZeneca
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.